Q32 Bio Inc (FRA:DB0)
€ 11.33 -0.020 (-0.18%) Market Cap: 191.18 Mil Enterprise Value: 158.60 Mil PE Ratio: 4.60 PB Ratio: 4.06 GF Score: 17/100

Q32 Bio Inc Annual Shareholders Meeting Transcript

Jun 12, 2026 / 12:30PM GMT
Release Date Price: €10.89 (-2.24%)
Operator

Hello and welcome to the 2026 virtual annual meeting of Q32 Bio Inc. Please note that today's meeting is being recorded. Stockholders may submit questions by following the instructions on the annual meeting interface.

Jodie Morrison
Q32 Bio Inc - Chief Executive Officer, Director

Good morning, everyone. My name is Jodi Morrison, Chief Executive Officer of Q32 Bio.

The meeting is now called to order. I've asked Jackie Mercier of Goodwin Procter, our outside legal counsel, to record the minutes. It is a pleasure to welcome our stockholders to the annual meeting of Q32 Bio. This meeting is being held in accordance with the corporation's bylaws and Delaware law.

The purpose of the meeting is the formal business at hand, which was described in our notice and proxy statement, a copy of which was mailed on or about April 30, 2026, to all of our stockholders of record at the. Of business on April 15, 2026. All discussions will be limited to the official business at hand.

Before we proceed to the formal business, I would like to welcome

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot